BCI
ALT icon

Brinker Capital Investments’s Altimmune ALT Stock Holding History

Brinker Capital Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,943
Closed -$152K – 1715
2024
Q1 		$152K Buy
14,943
+48
+0.3% +$488 ﹤0.01% 1634
2023
Q4 		$170K Buy
+14,895
New +$62.2K ﹤0.01% 1596

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brinker Capital Investments's ALT Position: Q2 2024 in Review

Brinker Capital Investments sold out of Altimmune (ALT) in Q2 2024, closing a stake of 14,943 shares — an estimated $152K sold.

Brinker Capital Investments first reported a position in ALT in Q4 2023 and held it in 2 quarters. The position peaked at $170K in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Brinker Capital Investments reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Brinker Capital Investments sold 14,943 Altimmune shares in Q2 2024, an estimated $152K.
  • Brinker Capital Investments first reported a position in Altimmune in Q4 2023 and held it in 2 quarters.
  • Brinker Capital Investments's Altimmune position peaked at $170K in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Brinker Capital Investments's 13F filing for Q2 2024, filed 31 Jul 2025.